Active Biotech develops innovative pharmaceuticals that modulate the body's own immune system.We focus on widespread diseases for which a tremendous need is felt for new and more effective treatments.

2008-06-30	Number of shares and votes in Active Biotech
2008-06-24	RhuDex® Achieves Positive Results in Clinical Phase IIa Trial
2008-06-20	Active Biotech's Novel MS Compound laquinimod Featured in the Scientific Publication The Lancet
2008-06-12	Active Biotech's new issue fully subscribed
2008-05-15	Active Biotech to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
2008-05-15	Announcement of prospectus regarding rights issue in Active Biotech AB (publ)

Active Biotech AB, Scheelevägen 22, P.O. Box 724, SE-220 07 Lund, Sweden, Telephone +46 46 19 20 00